MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
about
MicroRNAs in the DNA Damage/Repair Network and CancerDown-regulation of the microRNA-99 family members in head and neck squamous cell carcinomaPotential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate CancerEmerging molecular basis of hematogenous metastasis in gastric cancerComparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric CancerEmerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implicationsDysregulation of non-coding RNAs in gastric cancerMay Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewThe functional sites of miRNAs and lncRNAs in gastric carcinogenesisThe Effect of MicroRNA-375 Overexpression, an Inhibitor of Helicobacter pylori-Induced Carcinogenesis, on lncRNA SOX2OT.Non-coding RNAs and gastric cancerGastric Cancer in the Era of Precision Medicine.miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3ζmiR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expressionFunctional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.Specific Gene- and MicroRNA-Expression Pattern Contributes to the Epithelial to Mesenchymal Transition in a Rat Model of Experimental Colitis.Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functionsMiRNA profiling of gastrointestinal stromal tumors by next-generation sequencingDNA methylation of microRNA-375 in impaired glucose toleranceMiRNA as potential biomarkers and therapeutic targets for gastric cancer.Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesisEndobronchial miRNAs as biomarkers in lung cancer chemoprevention.Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cellsmiR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancerPrognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis.Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancerMiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population.Deciphering the unique microRNA signature in human esophageal adenocarcinomamiR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.A systematic review of microRNA expression profiling studies in human gastric cancer.Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis.Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
P2860
Q21284509-E5E15011-5F56-4C14-AE0B-407EB4AAB948Q24600829-53AF6341-9EA6-451D-A805-100478C63A51Q26744362-292A3547-EF70-4D49-B770-76003AD80007Q26748881-2B47F8B7-23F6-44C8-8D91-4949CF11CFFAQ26751983-44F8638C-B159-49E5-9383-79AB536BC437Q26764924-251D780D-02DA-4D33-B540-29A5BAAC0DB0Q26771422-95D07E6B-E62B-4DF8-8C77-8F76C07F17B0Q26774498-49E361C9-7F58-4A39-8011-79E0EC592E61Q26780293-4B8EADD0-F752-43EF-BC30-1DFAB7E924EAQ26780339-BFBA29D3-5B43-4D11-9F0B-E09F2B48BF3DQ26785539-825332E4-A6D1-46D9-8FC9-D4FE71DF0261Q27026837-358DEBA4-5344-4014-A26A-73D095A83242Q30371417-DD6A3D5D-2D00-4402-AC4C-7E0A7CA448BDQ33594919-6980D307-7AB1-4869-AF11-6E014A88FDE8Q33600457-AD8559F5-CDF7-4257-A79D-F09DDFDB940BQ33614271-05B4858B-8D1F-4BBC-BE61-C35B660870F6Q33706171-B6F8F0CC-F58A-43C8-9AF1-0BAC3915B6B5Q33706508-01566FB4-B1E7-436C-B312-BE542650B954Q33721273-E10FE034-3681-4625-A15B-5F4AC777BFC8Q33791173-61DFC5E7-8474-4644-8477-0CC67296ED02Q33913895-AD0EB74C-2EE4-45E2-B2A9-03BE20BA4790Q33962117-A3575EA5-46CB-4F4D-8C84-26E5FA20DF39Q34036679-BA6EFD6D-A320-4635-BBBB-7315B0513BBFQ34036835-5CD23C23-A64C-49E1-9965-8479CFF2538DQ34087915-0B8D7791-8E87-4A8C-B5AB-C1631FBC5F15Q34149750-CFD5CF82-6F6C-43DA-B79B-13728A461A5EQ34156076-858612AD-F230-4924-92FA-EB08E8C5636FQ34273930-E2CE2981-899F-452E-B036-B234D7AA7A8CQ34351442-694FD96C-54AA-44A1-8583-7ACAB6B146F7Q34384632-30F38E81-E4D8-49DD-9520-0D72112489A6Q34488086-79E85D38-A072-41C3-89DC-2AC59020DC76Q34648156-308CF0CB-F524-4C95-9D54-035967D4F3F1Q34696685-4C507CF3-F71D-4E9E-91A4-A80195309B81Q34746150-B8FA5908-2794-4407-A9C6-FEED5C2A9B94Q34749597-FE89A15D-151B-48E1-AB2C-75A4A27E8993Q34981594-E6E2E2BA-A714-4DF6-B7B2-CF2FCE9B2D44Q34989110-2F45AB36-BE67-4779-A223-A3AD8E0561C4Q35000434-A7A08D74-4798-4273-96EC-56FEC48ACC10Q35043503-677A55BB-2214-4EB5-BD00-2928E5C1E0DDQ35110766-014D4156-06B1-4D0C-BA1E-B427FD3B1FC6
P2860
MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@ast
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@en
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@nl
type
label
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@ast
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@en
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@nl
prefLabel
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@ast
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@en
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@nl
P2093
P2860
P356
P1433
P1476
MiR-375 frequently downregulat ...... oliferation by targeting JAK2.
@en
P2093
Jianmin Si
Tianhua Zhou
P2860
P2888
P304
P356
10.1038/CR.2010.79
P577
2010-06-15T00:00:00Z
P5875
P6179
1003569803